SCHEMBL5482067

SCHEMBL5482067

OCCCCCC(O)C(O)CCCCO

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.46
TRPA1 O75762 1/20 0.46
LMNA P02545 3/20 0.41
CYP2D6 P10635 2/20 0.41
SPHK1 Q9NYA1 2/20 0.41
CYP3A4 P08684 2/20 0.41
GMNN O75496 1/20 0.41
POLB P06746 1/20 0.41
THPO P40225 1/20 0.41
MTOR P42345 1/20 0.41
BLM P54132 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
MAPT P10636 1/20 0.41
CETP P11597 1/20 0.41
HTT P42858 1/20 0.41
UBE2N P61088 1/20 0.41
ALDH1A1 P00352 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21552219 1.00 TRPV1 (0.46) TRPV1TRPA1LMNACYP2D6SPHK1
SCHEMBL29623180 1.00 TRPV1 (0.46) TRPV1TRPA1LMNACYP2D6SPHK1
SCHEMBL8503320 1.00 TRPV1 (0.46) TRPV1TRPA1LMNACYP2D6SPHK1
SCHEMBL21552377 1.00 TRPV1 (0.46) TRPV1TRPA1LMNACYP2D6SPHK1
SCHEMBL4006613 1.00 TRPV1 (0.46) TRPV1TRPA1LMNACYP2D6SPHK1
SCHEMBL24176357 1.00 TRPV1 (0.46) TRPV1TRPA1LMNACYP2D6SPHK1
SCHEMBL15848372 1.00 TRPV1 (0.46) TRPV1TRPA1LMNACYP2D6SPHK1
SCHEMBL339595 0.97 TRPV1 (0.43) TRPV1TRPA1LMNACYP2D6SPHK1
SCHEMBL3399170 0.97 TRPV1 (0.41) TRPV1TRPA1LMNACYP2D6SPHK1
SCHEMBL11346601 0.94 TRPV1 (0.42) TRPV1TRPA1LMNACYP2D6SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219388-A1 Preparation of aliphatic oligocarbonate diols COVESTRO DEUTSCHLAND AG (DE) 2007-09-20 US claimed
US-20040171867-A1 Reactive monomer composition modified by a small-amount of lactones, an acrylic polyol resin, a curable resin composition, and a coating composition OKAZAKI AKIRA (JP) 2004-09-02 US disclosed
EP-0832945-B1 Coating agent composition and composite film DOW CORNING TORAY SILICONE (JP) 2000-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171867-A1 Reactive monomer composition modified by a small-amount of lactones, an acrylic polyol resin, a curable resin composition, and a coating composition MSR1, FUT4, MRE11 TRPV1 3379/4885TRPA1 2869/4885LMNA 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.